2024-SABCS-Takeaways - 3

Scan this QR code on your
smartphone to listen to the podcast
ADC Cast is a non-promotional educational podcast series
dedicated to antibody drug conjugates (ADCs) in breast cancer.
Chair:
Dr Javier Cortés
Chair:
Prof. Peter Schmid
Hosted by Dr Javier Cortés and Prof. Peter Schmid, joined by an international panel of
experts in ADCs and breast cancer, this educational podcast series unveils invaluable
insights into ADCs, shedding light on their developmental history, their distinctive
structural features and mechanisms of action, as well as potential future advancements.
Episode 1
Episode 2
Episode 3
Episode 4
Episode 5
Episode 6
How did we get there? The history of ADC development
Chair: Dr Javier Cortés (Spain)
Dr Komal Jhaveri (US) & Prof. Peter Schmid (UK)
Important aspects of ADC structure
Chair: Dr Javier Cortés (Spain)
Dr Erika Hamilton (US) & Dr Kevin Punie (Belgium)
ADC antigen targets: what are we aiming at?
Chair: Prof. Peter Schmid (UK)
Dr Christine Brezden-Masley (Canada) & Dr Kevin Kalinsky (US)
Understanding the ADC bystander effect
Chair: Prof. Peter Schmid (UK)
Prof. Dr. Frederik Marmé (Germany) & Dr Barbara Pistilli (France)
The safety profile of ADCs in breast cancer
Chair: Dr Javier Cortés (Spain)
Dr Aditya Bardia (US) & Dr Mafalda Oliveira (Spain)
What's on the horizon for ADCs?
Chair: Prof. Peter Schmid (UK)
Dr Javier Cortés (Spain) & Prof. Rebecca Alexandra Dent (Singapore)
This is a non-promotional educational podcast series dedicated to US healthcare professionals only.
Chairs and speakers received compensation from Gilead for their contributions.
This podcast series was funded and produced by Gilead Sciences, Inc. © 2024 Gilead Sciences, Inc.
All rights reserved. GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc.

https://real-chemistry.stationista.com/subscribe/66101332ff219157a7061eaa/qf4QJBOtognqWx4qXCyZvN1uGWbbHT25OGuldwCVVomsG2MExj

2024-SABCS-Takeaways

Table of Contents for the Digital Edition of 2024-SABCS-Takeaways